OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
Luiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e004150-e004150
Open Access | Times Cited: 16

Showing 16 citing articles:

Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Radomir M. Slominski, Tae‐Kang Kim, Zorica Janjetović, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2262-2262
Open Access | Times Cited: 17

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
Lihaoyun Huang, Haitao Li, Cangang Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 6

Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions
Andrea L Cote, Chad J. Munger, Alison E. Ringel
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115234-115234
Closed Access

Steroid hormones as modulators of anti-tumoural immunity
Paul Schwarzlmüller, Alexandra Triebig, Guillaume Assié, et al.
Nature Reviews Endocrinology (2025)
Closed Access

Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses
George Anderson
Exploration of Targeted Anti-tumor Therapy (2023), pp. 962-993
Open Access | Times Cited: 10

Targeting metabolic pathways to counter cancer immunotherapy resistance
Yuki Agarwala, Timothy Brauns, Ann E. Sluder, et al.
Trends in Immunology (2024) Vol. 45, Iss. 7, pp. 486-494
Closed Access | Times Cited: 3

Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer
Hélène Poinot, Eloïse Dupuychaffray, Grégoire Arnoux, et al.
OncoImmunology (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6

Bone marrow-derived mesenchymal stem cell ameliorates post-stroke enterobacterial translocation through liver-gut axis
Xiaotao Su, Tiemei Li, Yuge Wang, et al.
Stroke and Vascular Neurology (2024), pp. svn-003494
Open Access | Times Cited: 1

Immunochemotherapy for small cell lung cancer with paraneoplastic Cushing syndrome: A case report and literature review
Ling Yu, Yanlong Li, Caiyu Li, et al.
Medicine (2024) Vol. 103, Iss. 51, pp. e41036-e41036
Open Access | Times Cited: 1

Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma
Jan-Malte Placke, Jenny Bottek, Renáta Váraljai, et al.
British Journal of Dermatology (2024)
Closed Access | Times Cited: 1

Subclone from CT26 resistant to anti-PD-1 therapy associated with increased expression of genes related to glucocorticoids
Yangyang Zhang, Chaoji Zhang, Guangyu Chen, et al.
Translational Oncology (2024) Vol. 46, pp. 102031-102031
Open Access

Prognostic biomarkers for immunotherapy in esophageal cancer
Tong Xu, Meiyuan Jin, Lulu Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Biosynthesis of glucocorticoids in tumors. Reply.
Matthew D. Taves, Shizuka Otsuka, Jonathan D. Ashwell
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access

Page 1

Scroll to top